Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
291
-
Total 13F shares, excl. options
-
72M
-
Shares change
-
-4.15M
-
Total reported value, excl. options
-
$954M
-
Value change
-
-$55.4M
-
Put/Call ratio
-
0.02
-
Number of buys
-
134
-
Number of sells
-
-134
-
Price
-
$13.24
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2024
338 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2024.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 291 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72M shares
.
Largest 10 shareholders include Capital Research Global Investors (13.2M shares), MORGAN STANLEY (5.6M shares), GOLDMAN SACHS GROUP INC (4.63M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (4.22M shares), FMR LLC (3.39M shares), FIRST TRUST ADVISORS LP (3.24M shares), RENAISSANCE TECHNOLOGIES LLC (3.08M shares), BRANDES INVESTMENT PARTNERS, LP (3.04M shares), VAN ECK ASSOCIATES CORP (2.21M shares), and BlackRock, Inc. (2.2M shares).
This table shows the top 291 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.